Clinical Trials List
2016-03-01 - 2023-10-31
Phase III
Terminated8
ICD-10M06.9
Rheumatoid arthritis, unspecified
ICD-10M05
Rheumatoid arthritis with rheumatoid factor
ICD-9714.0
Rheumatoid arthritis
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- CHIEH-YU SHEN 風濕免疫科
- KO-JEN LI 風濕免疫科
- PING-NING HSU 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Po-Hao Huang 風濕免疫科
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen Chan Tsai 風濕免疫科
- Sung Wan-Yu 風濕免疫科
- 歐燦騰 風濕免疫科
- 吳正欽 風濕免疫科
- Jeng-Hsien Yen 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsien-Tzung Liao Division of Rheumatology
- Wei-Sheng Chen Division of Rheumatology
- Chang-Youh Tsai Division of Rheumatology
The Actual Total Number of Participants Enrolled
3 Terminated
Audit
CRO
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Ping-Han Tsai Division of Rheumatology
- Yao-Fan Fang Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- TianMing Zhan Division of Rheumatology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
- Wen Chan Tsai 未分科
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
1629 participants
